Navigation Links
Ph.D. Peptide Display Cloning System from New England Biolabs

ProductsPh.D. Peptide Display Cloning System from New England Biolabs
Company New England Biolabs
Item Ph.D. Peptide Display Cloning System
Price 
Description The Ph.D. Peptide Display Cloning System facilitates the display of custom peptide libraries on the surface of bacteriophage M13 as coat protein fusions, creating a physical linkage between each displayed peptide and its encoding DNA sequence. Peptide ligands for a variety of targets can then be selected by the straightforward method of biopanning. The supplied display vector M13KE is an M13 derivative with cloning sites engineered for N-terminal pIII fusion, resulting in a valency of 5 displayed peptides per virion. The use of a phage vector, rather than a phagemid, simplifies the intermediate amplification steps, since neither antibiotic selection nor helper phage superinfection are required. Since displayed proteins longer than 20-30 amino acids have a deleterious effect on the infectivity function of pIII in phage vectors, this vector is suitable only for the display of short peptides. Included with the cloning vector is an insert extension primer as well as a detailed protocol for cloning a peptide libra
Info New England BiolabsNew England Biolabs
32 Tozer Rd.
Beverly, MA 01915-5599

Customer Service: 800-632-5227
Tech Support: 800-632-7799
Fax Number: 978-921-1350
Web Site: http://www.neb.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Ph.D.-12 Peptide 12-mer Library Kit from New England Biolabs
2. Ph.D.-C7C Disulfide Constrained Peptide Library Kit from New England Biolabs
3. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
4. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
5. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
6. Human and Mouse RAR Neutralizing Peptide from ABR-Affinity BioReagents
7. Epitope Peptide Microarray - Comprehensive Service from LC Sciences
8. Custom Peptide Microarray - Comprehensive Service from LC Sciences
9. Peptide Synthesis from Sigma-Genosys
10. Rat rab 3D Neutralizing Peptide from ABR-Affinity BioReagents
11. Rat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents
... tested on rat tissue extracts (liver, kidney, spleen, ... cerevisae ) extract. It was also tested with ... lines. Application: A simple and reliable method for ... the detection of the inorganic phosphate released from ...
... the leader in electroporation products and specialty ... product line for experiment optimization and large ... a breakthrough in Molecular Delivery. The days ... that typically limited the number of samples ...
... 20 System revolutionizes DNA sequencing, delivering sequence ... The Genome Sequencer 20 System includes: ... consumables for library construction, amplification, and sequencing ... novo assembly The instrument ...
... RapidVUE is a particle shape and size analyzer ... designed with the utmost simplicity in mind. It ... module and an optical bench. The system is ... easy upgrade for different applications such as dry ...
Biology Products:
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... study, "Socioeconomic Conditions Along the World,s Tropical Coasts: 2008," ... healthy coral reefs in 27 tropical nations and points ... decades-old recommendations as a significant barrier to coral reef ... quadrennial "Status of Coral Reefs of the World: 2008" ...
... of the bowel can have genetic causes. Researchers at ... have discovered this correlation. The causes of what is ... most common disorders of the gastrointestinal tract, are considered ... results from Heidelberg, which were published in the prestigious ...
... Michigan State University chemist could eventually lead to a ... are key to treating a number of diseases, including ... manufacture and research often are made within genetically modified ... tends to collect into what scientists call inclusion bodies. ...
Cached Biology News:First-ever socioeconomic study on coral reefs points to challenges of coastal resource management 2First-ever socioeconomic study on coral reefs points to challenges of coastal resource management 3Irritable bowel syndrome can have genetic causes 2
(Date:2/27/2015)... February 27, 2015 Immunovaccine Inc. ... immunotherapy company, today announced that the U.S. Food ... Fast Track designation and Phase I clinical trials ... with the mutual co-development agreement signed with Gilead ... Track designation for the DPX-Survivac. , “We have ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FamilyFarms Group ... General Manager of State Line Farms, received the 2015 ... a producer, under the age of 35, who has ... is an honor to win the Tomorrow's Top Producer ... who won the Top Producer Award and learning from ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... --  Synageva BioPharma Corp. (NASDAQ: ... for rare disorders, today reported 2014 full year ... objectives, and financial guidance.  Synageva,s management team will ... EST to review the financial results and provide ... call by telephone, please dial (877) 445-4603 for ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9